Subscribe
Share
Share
Embed
April 21, 2026
A Podcast on Tirzepatide SURMOUNT-OSA trial and cardiometabolic subanalysis.
A portion of the ATS SRN 360 high impact articles from the past year.
• Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity – Presented by Richard J Schwab, MD - Perelman School of Medicine, University of Pennsylvania, Philadelphia; the Division of Sleep and Circadian Disorders
• Tirzepatide on obstructive sleep apnea-related cardiometabolic risk: secondary outcomes of the SURMOUNT-OSA randomized trial.
Presented by Scott A. Sands, Ph.D - Brigham and Women’s Hospital and Harvard Medical School in Boston, Massachusetts
Moderated by Chana Chin, MD from CHOC Children's/Rady's Children's Health and Bradon Nokes, MD from University of California, San Diego
00:00 — Podcast Introduction & Presentation Overview
A Podcast on Tirzepatide SURMOUNT-OSA trial and cardiometabolic subanalysis.
A portion of the ATS SRN 360 high impact articles from the past year.
• Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity – Presented by Richard J Schwab, MD - Perelman School of Medicine, University of Pennsylvania, Philadelphia; the Division of Sleep and Circadian Disorders
• Tirzepatide on obstructive sleep apnea-related cardiometabolic risk: secondary outcomes of the SURMOUNT-OSA randomized trial.
Presented by Scott A. Sands, Ph.D - Brigham and Women’s Hospital and Harvard Medical School in Boston, Massachusetts
Moderated by Chana Chin, MD from CHOC Children's/Rady's Children's Health and Bradon Nokes, MD from University of California, San Diego
00:00 — Podcast Introduction & Presentation Overview
00:15 — Tirzepatide for Obstructive Sleep Apnea and Obesity
00:47 — SURMOUNT-OSA Trial Design and Patient Population
01:44 — Primary Endpoints and Secondary Outcome Measures
02:53 — Baseline Demographics and Clinical Characteristics
03:52 — Weight Loss Effects and Sleep Apnea Improvement Results
05:52 — Cardiometabolic Outcomes, Blood Pressure, and Safety Findings
08:40 — Clinical Discussion: Prescribing Tirzepatide in OSA Practice
12:03 — Secondary Analysis of Cardiometabolic Risk Mediation
20:08 — Long-Term Use, Mechanisms of Action, and Audience Q&A
Creators and Guests
Host
Chana Chin, MD
Children's Hospital Orange County Pediatric Pulmonary and Sleep Medicine part of Rady's Children's Health, California, United States -Division of Pediatric Pulmonary and Sleep Medicine and Physiology, Orange, California
Guest
Brandon Nokes, MD
Sleep Medicine Section, Veterans Affairs San Diego Healthcare System, San Diego, California
Guest
Richard J. Schwab, MD
Professor of Medicine (Sleep Medicine) at the Hospital of the University of Pennsylvania
Guest
Scott A. Sands, Ph.D.
Associate Professor of Medicine, Brigham and Women's Hospital and Harvard Medical School
What is ATS Assemblies & Sections?
Discussions about pulmonary, critical care, and sleep medicine from our Assemblies & Sections.